TGFBR1 and non-small cell lung carcinoma: We observed that the inhibition of TGFR-1, alone or in combination with EGFR inhibition, did not affect NSCLC cell lines survival, but it was able to partially decrease the number of Vimentin positive cells in some HCC827-derived erlotinib-resistant cell lines.